| scholarly article | Q13442814 |
| P50 | author | Pierre Croisille | Q42361162 |
| Nathan Mewton | Q89461708 | ||
| Hugo Bernelin | Q92017990 | ||
| P2093 | author name string | Philippe Douek | |
| Gilles Rioufol | |||
| Michel Ovize | |||
| Claire Jossan | |||
| Eric Bonnefoy-Cudraz | |||
| Salim Si-Mohamed | |||
| Thomas Bochaton | |||
| Camille Amaz | |||
| Nathalie Dufay | |||
| P2860 | cites work | Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics | Q27004000 |
| Angiotensin-neprilysin inhibition versus enalapril in heart failure | Q28247091 | ||
| EQ-5D: a measure of health status from the EuroQol Group | Q34086093 | ||
| Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide | Q37558988 | ||
| Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care | Q37835560 | ||
| Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance | Q38476990 | ||
| Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis | Q38497913 | ||
| Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease. | Q38773708 | ||
| A Test in Context: Neprilysin: Function, Inhibition, and Biomarker | Q39523707 | ||
| Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction. | Q40149965 | ||
| Prognostic Value and Kinetics of Soluble Neprilysin in Acute Heart Failure: A Pilot Study. | Q40649865 | ||
| Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology | Q40897323 | ||
| Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure | Q41505812 | ||
| Studies on the enzymology of purified preparations of brush border from rabbit kidney | Q41763733 | ||
| Candidate leukaemia-specific antigen in man | Q43709882 | ||
| C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
| Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients. | Q48331571 | ||
| Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy | Q48468846 | ||
| Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction. | Q52991956 | ||
| LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice. | Q53214797 | ||
| Third Universal Definition of Myocardial Infarction | Q56535247 | ||
| A monoclonal antibody to human acute lymphoblastic leukaemia antigen | Q58415273 | ||
| Inside ST-elevation myocardial infarction by monitoring concentrations of cardiovascular risk biomarkers in blood | Q61851600 | ||
| CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation | Q67700741 | ||
| Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct | Q73274562 | ||
| Natriuretic peptides | Q74817622 | ||
| Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction | Q86868338 | ||
| Soluble neprilysin retains catalytic activity in heart failure | Q87198238 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 32-38 | |
| P577 | publication date | 2018-12-10 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Neprilysin levels at the acute phase of ST-elevation myocardial infarction | |
| P478 | volume | 42 |
| Q99565811 | Neprilysin as a Biomarker: Challenges and Opportunities | cites work | P2860 |
Search more.